Edwards Lifesciences Corp. Earnings

Edwards Lifesciences Corp.’s revenue jumped 10.56% since last year same period to $1532.2Mn in the Q2 2025. On a quarterly growth basis, Edwards Lifesciences Corp. has generated 8.46% jump in its revenue since last 3-months.

Edwards Lifesciences Corp.’s net profit fell -9.32% since last year same period to $329.8Mn in the Q2 2025. On a quarterly growth basis, Edwards Lifesciences Corp. has generated -7.88% fall in its net profits since last 3-months.

Edwards Lifesciences Corp.’s net profit margin fell -17.98% since last year same period to 21.52% in the Q2 2025. On a quarterly growth basis, Edwards Lifesciences Corp. has generated -15.06% fall in its net profit margins since last 3-months.

Edwards Lifesciences Corp.’s price-to-earnings ratio after this Q2 2025 earnings stands at 33.85.

Edwards Lifesciences Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.59 - a -5.34% fall from last quarter’s estimates.

Edwards Lifesciences Corp.’s earning per share (EPS) estimates for the current year stand at 0.59.

Edwards Lifesciences Corp.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Edwards Lifesciences Corp. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.